chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Drug ineffective
Clinical narrative: Got COVID; Got COVID; This is a spontaneous report received from a Consumer or other non HCP.  A female patient received BNT162b2 omi xbb.1.5 (COMIRNATY (2023-2024 FORMULA)), in Nov2023 as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant) all with onset 19Jan2024, outcome "unknown" and all described as "Got COVID". The caller called in for herself as she got Pfizer vaccine in November but they she got COVID in 19Jan. Caller would like to know if she should still get another vaccination.   The information on the batch/lot number for BNT162b2 omi xbb.1.5 will be requested and submitted if and when received.
Sex: U
Vaccine: MEN
Symptoms: No adverse event, Product storage error
Clinical narrative: temperature reached 0.34C for 476 mins (7.8 hours) with no reported adverse event; products have been used after excursion with no reported adverse event; Initial information received on 20-Mar-2024 regarding an unsolicited valid  non-serious case received from a other health professional.  This case involves an unknown age and unknown gender patient and reporter reported that the vaccine MENINGOCOCCAL A-C-Y-W135 (T CONJ) VACCINE [MENQUADFI] reached temperature of 0.34c for 476 mins (7.8 hours) and products have been used after excursion with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received a dose of suspect MENINGOCOCCAL A-C-Y-W135 (T CONJ) VACCINE (lot U7450AB, dose, strength, expiry date was unknown) via unknown route in unknown administration site as prophylactic vaccination and the product was exposed to temperature reached 0.34c for 476 mins (7.8 hours) (product storage error) and products have been used after excursion with no reported adverse event (poor quality product administered) (unknown latency). It was unknown if there was any human error involved.   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 3.0
Sex: M
Vaccine: UNK
Symptoms: Expired product administered, No adverse event
Clinical narrative: expired pentacel given with no reported adverse event; Initial information received on 25-Mar-2024 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves a 3 years old male patient to whom expired pentacel given with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On 25-Mar-2024, the patient received 0.5 ml of suspect DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(VERO)/HIB(PRP/T) VACCINE, Suspension for injection lot UJ870AA, expiry- 24-Mar-2024 via intramuscular route in the left thigh for immunization (strength unknown) with no reported adverse event (expired product administered) (latency same day).   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Sex: M
Vaccine: HIBV
Symptoms: Expired product administered, No adverse event
Clinical narrative: expired ACTHIB was given to a patient with no reported adverse event; Initial information received on 26-Mar-2024 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves a 14 months old male patient to whom expired acthib was given to a patient with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On 26-Mar-2024, the patient received 0.5 ml HIB (PRP/T) VACCINE, Powder and solvent for solution for injection lot UJ8558A expiry- 22-Mar-2024 via intramuscular route in the right vastus lateralis for immunization (strength unknown) with no reported adverse event (expired product administered) (latency same day).   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 1.0
Sex: F
Vaccine: UNK
Symptoms: Expired product administered, No adverse event
Clinical narrative: inadvertently administered an expired dose of pentacel with no reported ae; Initial information received on 26-Mar-2024 regarding an unsolicited valid  non-serious case received from a nurse.  This case involves a 1 years old female patient who was inadvertently administered an expired dose of Diphtheria/Tetanus/5 Hybrid Ac Pertussis/Ipv(Vero)/Hib(Prp/T) Vaccine [Pentacel (Vero)] with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included measles vaccine, mumps vaccine, rubella vaccine (mmr) for prophylactic vaccination; hepatitis a vaccine (hepatitis a) for prophylactic vaccination; and pneumococcal vaccine (pneumococcal vaccine) for prophylactic vaccination.  On 25-Mar-2024, the patient received 0.5 ml total of suspect Diphtheria/Tetanus/5 Hybrid Ac Pertussis/Ipv(Vero)/Hib(Prp/T) Vaccine Suspension for injection (lot UJ877AA) (Expiry date: 22-Mar-2024) (with an unknown strength) via intramuscular route in the left thigh for immunization.  On 25-mar-2024, the patient was inadvertently administered an expired dose of Diphtheria/Tetanus/5 Hybrid Ac Pertussis/Ipv(Vero)/Hib(Prp/T) Vaccine [Pentacel (Vero)] with no reported adverse event (expired product administered) (latency: same day).  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 1.33
Sex: F
Vaccine: HIBV
Symptoms: Expired product administered, No adverse event
Clinical narrative: 1-year-old female was administered with an expired ACTHIB with no reported adverse event; Initial information received on 26-Mar-2024 regarding an unsolicited valid non-serious case received from a physician.  This case involves a 1 years old female patient who was administered with an expired acthib with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On 26-Mar-2024, the patient received 0.5 ml dose of suspect HIB (PRP/T) VACCINE, Powder and solvent for solution for injection lot UJ863AA, expiry date-  25-Mar-2024 via intramuscular route in the right thigh for immunization (strength unknown) with no reported adverse event (expired product administered) (latency same day).   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 60.0
Sex: M
Vaccine: RSV
Symptoms: Rash, Urticaria
Clinical narrative: PATIENT STATED HE DEVELOPED RASH/HIVES ON HIS CHEST FACE BUT IT WAS MILD ON 03/25/24. HE TOOK SOME ANTIHISTAMINES CETIRIZINE 10MG OVER THE COUNTER ON 03/27/24 AND IT HAS NOW SUBSIDED.
Age: 74.0
Sex: F
Vaccine: VARZOS
Symptoms: Erythema, Injected limb mobility decreased, Injection site pain, Skin discolouration
Clinical narrative: Unbareable pain in my right arm where the shot was given. I couldnt lift my left arm up either. Redness up and down both arms. It then turned a purple/blue color on both arms but more so on the right and less on the left. This lasted about 3 weeks.
Age: 52.0
Sex: M
Vaccine: MENB
Symptoms: Product administered to patient of inappropriate age
Clinical narrative: listed vaccine removed and administered to incorrect age of patient
Age: 73.0
Sex: M
Vaccine: PNC20
Symptoms: Device leakage, Immunisation, Underdose
Clinical narrative: 25G/1in  needle was attached to the prefilled syringe.  After insertion into the left deltoid, the plunger was depressed.  Almost immediately the contents of the syringe squirted out from the area just below the  luer-lock attachment point of the syringe.  From the amount of liquid that leaked out, it is assumed that the pt received very little(if any) of the intended dose.  To provide a valid vaccination, a second syringe was administered to the patient.
Age: 66.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Patient received second shingles shot on 03/25 then reported 03/28 an adverse reaction. Patient's arm had localized swelling and redness which was warm to the touch. Swelling was below the area of injection site  on the left arm. Advised patient to continue therapy of PRN ibuprofen, rest, and ice for pain and swelling. Advised pt to mark area of redness and swelling and contact md if worsening.
Age: 75.0
Sex: F
Vaccine: RSV, VARZOS
Symptoms: Injection site erythema, Injection site rash, Injection site warmth
Clinical narrative: Patient had Redness, bumps and hot areas on arms around injection site
Age: 72.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema
Clinical narrative: Redness at injection site.  No fever,. The redness is about the size of an apple . We recommended patient to do cold compress at home.
Age: 6.0
Sex: F
Vaccine: TDAP
Symptoms: Influenza virus test negative, Injection site erythema, Injection site swelling, Pyrexia, SARS-CoV-2 test negative
Clinical narrative: Upon waking up the following morning after receiving the vaccine pt had a 103.6 fever. She was seen in two emergency departments the following day, 3/28/24. On 3/28/24 at 350pm pt had a fever of 105.1. Her injection site appeared very swollen and red.
Age: 6.0
Sex: F
Vaccine: TDAP
Symptoms: Streptococcus test negative
Clinical narrative: Upon waking up the following morning after receiving the vaccine pt had a 103.6 fever. She was seen in two emergency departments the following day, 3/28/24. On 3/28/24 at 350pm pt had a fever of 105.1. Her injection site appeared very swollen and red.
Age: 38.0
Sex: M
Vaccine: COVID19, FLU4
Symptoms: Expired product administered, No adverse event
Clinical narrative: The patient received an expired vaccine. No actual reaction occurred with the patient after administrating.
Age: 12.0
Sex: M
Vaccine: HEPA, VARCEL
Symptoms: Inappropriate schedule of product administration
Clinical narrative: None observed; HEP A Dose #2 received too early.  Recorded is ASIIS as non-dose.
Sex: M
Vaccine: COVID19
Symptoms: Hypoacusis
Clinical narrative: Reported Symptoms: 10019245:HEARING IMPAIRED; Narrative: Other Relevant HX: Other: HEARING IMPAIRMENT
Sex: M
Vaccine: FLUX
Symptoms: Rash
Clinical narrative: Reported Symptoms: 10037844:RASH;    Narrative:  Other Relevant HX:
Age: 64.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Fatigue, Sedation
Clinical narrative: Reported Symptoms: 10016256:FATIGUE; 10039897:SEDATION; 10047862:WEAKNESS; Narrative: Other Relevant HX: Other: FATIGUE; WEAKNESS
Sex: M
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Reported Symptoms:  10019211:HEADACHE;  Narrative: Other Relevant HX:
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: Breakthrough COVID-19, COVID-19, Fatigue, Post-traumatic stress disorder, Productive cough
Clinical narrative: Reported Symptoms: 10067923:VACCINE BREAKTHROUGH INFECTION; Narrative: Patient admitted to the in-patient psychiatric unit (08/05/2021) for poly-substance abuse and PTSD management. On 09/04/2021, patient tested posted via PCR test for COVID-19. He was vaccinated with one dose of J&J COVID-19 Immunization (03/31/2021). He presented with a cough with mild production of sputum and fatigue, but maintained adequate O2 sats. Patient required to COVID-19 specific treatments. He was discharged (9/5/2021) from the program to isolate in his family camper. Other Relevant HX: PTSD, generalized anxiety disorder, OSA, asthma, amphetamine dependence, tobacco use, heroin dependence Other: COVID-19 breakthrough infection
Age: 39.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Substance abuse, Vaccine breakthrough infection
Clinical narrative: Reported Symptoms: 10067923:VACCINE BREAKTHROUGH INFECTION; Narrative: Patient admitted to the in-patient psychiatric unit (08/05/2021) for poly-substance abuse and PTSD management. On 09/04/2021, patient tested posted via PCR test for COVID-19. He was vaccinated with one dose of J&J COVID-19 Immunization (03/31/2021). He presented with a cough with mild production of sputum and fatigue, but maintained adequate O2 sats. Patient required to COVID-19 specific treatments. He was discharged (9/5/2021) from the program to isolate in his family camper. Other Relevant HX: PTSD, generalized anxiety disorder, OSA, asthma, amphetamine dependence, tobacco use, heroin dependence Other: COVID-19 breakthrough infection
Sex: M
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Reported Symptoms: 10019211:HEADACHE; Narrative: Other Relevant HX:
Age: 59.0
Sex: M
Vaccine: FLU4
Symptoms: Influenza like illness, Pyrexia
Clinical narrative: Reported Symptoms: 10016558:FEVER; 10016797:FLU-LIKE SYMPTOMS; Narrative: Other Relevant HX: Likely normal response to flu-not true ADR but will submit to system as documented on chart by provider. Other: FEVER, "flu like symptoms"
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, Pain in extremity
Clinical narrative: Reported Symptoms: 10067482: NO ADVERSE EVENT;    Narrative: atient contacted regarding recent COVID-19 immunization on 11/10/21.   Patient  arroneously received a full dose of Moderna vacccins instead of a half dose  booster per CDC guidelines.  Patient was provided this information and informed  that we would not expect any significant consequences as a result of this error.  Patient was asked aboout any potential adverse events and none were reported  other than saying his arm slightly hurt as it did with his other doses.  The patient  was appreciative of the phone call and agreed to contact the  pharmacy or his provider with any additional questions or adverse events.  Will  add his PCP to this note for awareness.  Other Relevant HX: Other: none
Age: 40.0
Sex: M
Vaccine: DTAP
Symptoms: Feeling abnormal, Paraesthesia, Pruritus, Sensation of foreign body
Clinical narrative: Reported Symptoms: 100033987:PARESTHESIA;     Narrative:  Forgot he was allergic to pertussis but signed the consent.   Patient presents to UCC 1 hour after vaccine.  Feels weird and has a lump in throat, no sob, no nausea,   no vomiting, no swelling of the lips or tongue, was itchy but resolved, no rash. Patient treated with benadryl and discharged from UCC. Other Relevant HX:  Other:  PARESTHESIA
Age: 40.0
Sex: M
Vaccine: DTAP
Symptoms: Feeling abnormal, Paraesthesia, Pruritus, Sensation of foreign body
Clinical narrative: Reported Symptoms: 10033987:PARESTHESIA; Narrative: Forgot he was allergic to pertussis but signed the consent. Patient presents to UCC 1 hour after vaccine. Feels weird and has a lump in throat, no sob, no nausea, no vomiting, no swelling of the lips or tongue, was itchy but resolved, no rash. Patient treated with benadryl and discharged from UCC. Other Relevant HX: Other: PARESTHESIA
Sex: M
Vaccine: FLUX
Symptoms: Arthralgia, Headache, Hyperhidrosis, Myalgia, Pyrexia
Clinical narrative: Reported Symptoms: 10003239:ARTHRALGIA; 10016558:FEVER; 10019211:HEADACHE; 10023222:JOINT PAIN; 10028322:MUSCLE PAIN; 10028411:MYALGIA; 10042661:SWEATING; Narrative: Other Relevant HX: Other: MUSCLE PAIN; HEADACHE; JOINT PAIN; SWEATING; FEVER
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Abnormal behaviour, Arrhythmia, Atelectasis, Blood pressure fluctuation, Breath sounds abnormal
Clinical narrative: Reported Symptoms: 10011906:DEATH; 10084380:COVID-19 PNEUMONIA; Narrative: Patient was a 77 y.o. male who acquired COVID-19 during a hospital stay where he had a rectosigmoidectomy from this surgery caused a (L) percutaneous nephrostomy tube to be placed. The patient tested positive for COVID-19 infection 08/17/2021 with a PCR test, symptom onset starting on 8/16/2021 . Patient's medical history included sleep apnea, his baseline O2 was 2L with CPAP at night. Upon admission on 8/19/2021 to a facility, he had a non-productive cough. Throughout his hospital stay, he required HFNC and BIPAP. Chest/lung exams showed: decreased/course breath sounds and mild labored breathing. CT/chest x-rays showed: plural effusion and basilar consolidation opacities, and atelectasis. Patient also had presentation of edema in thighs, congestion, high and low BP/HR/RR episodes, irriegular rate and rhythm of heart episodes, and behavioral episodes that consisted of yelling, disorientation, short term memory impairment, hallucinations, delirium. While in the hospital he received dexamethasone, hospital acquired penumonia empiric therapy (vancomycin and Zosyn, later Levaquin as well) and medications for his behavioral episodes. Patient passed away 8/27/2021. Other Relevant HX: partial L5 paraplegic, large, sacral decubitus, suprapubic catheter. rectosigmoidectomy for fistula turning into non-healing wound, bilateral below knee amputation, OSA, T2DM, Afib, h/o osteomyletis, h/o VTE, pulmonary hypertension,chronic pain, vitamin d deficiency, carpal tunnel, anemia, back
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, COVID-19 pneumonia, Chest X-ray abnormal, Computerised tomogram thorax abnormal, Cough
Clinical narrative: Reported Symptoms: 10011906:DEATH; 10084380:COVID-19 PNEUMONIA; Narrative: Patient was a 77 y.o. male who acquired COVID-19 during a hospital stay where he had a rectosigmoidectomy from this surgery caused a (L) percutaneous nephrostomy tube to be placed. The patient tested positive for COVID-19 infection 08/17/2021 with a PCR test, symptom onset starting on 8/16/2021 . Patient's medical history included sleep apnea, his baseline O2 was 2L with CPAP at night. Upon admission on 8/19/2021 to a facility, he had a non-productive cough. Throughout his hospital stay, he required HFNC and BIPAP. Chest/lung exams showed: decreased/course breath sounds and mild labored breathing. CT/chest x-rays showed: plural effusion and basilar consolidation opacities, and atelectasis. Patient also had presentation of edema in thighs, congestion, high and low BP/HR/RR episodes, irriegular rate and rhythm of heart episodes, and behavioral episodes that consisted of yelling, disorientation, short term memory impairment, hallucinations, delirium. While in the hospital he received dexamethasone, hospital acquired penumonia empiric therapy (vancomycin and Zosyn, later Levaquin as well) and medications for his behavioral episodes. Patient passed away 8/27/2021. Other Relevant HX: partial L5 paraplegic, large, sacral decubitus, suprapubic catheter. rectosigmoidectomy for fistula turning into non-healing wound, bilateral below knee amputation, OSA, T2DM, Afib, h/o osteomyletis, h/o VTE, pulmonary hypertension,chronic pain, vitamin d deficiency, carpal tunnel, anemia, back
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Delirium, Disorientation, Dyspnoea, Hallucination
Clinical narrative: Reported Symptoms: 10011906:DEATH; 10084380:COVID-19 PNEUMONIA; Narrative: Patient was a 77 y.o. male who acquired COVID-19 during a hospital stay where he had a rectosigmoidectomy from this surgery caused a (L) percutaneous nephrostomy tube to be placed. The patient tested positive for COVID-19 infection 08/17/2021 with a PCR test, symptom onset starting on 8/16/2021 . Patient's medical history included sleep apnea, his baseline O2 was 2L with CPAP at night. Upon admission on 8/19/2021 to a facility, he had a non-productive cough. Throughout his hospital stay, he required HFNC and BIPAP. Chest/lung exams showed: decreased/course breath sounds and mild labored breathing. CT/chest x-rays showed: plural effusion and basilar consolidation opacities, and atelectasis. Patient also had presentation of edema in thighs, congestion, high and low BP/HR/RR episodes, irriegular rate and rhythm of heart episodes, and behavioral episodes that consisted of yelling, disorientation, short term memory impairment, hallucinations, delirium. While in the hospital he received dexamethasone, hospital acquired penumonia empiric therapy (vancomycin and Zosyn, later Levaquin as well) and medications for his behavioral episodes. Patient passed away 8/27/2021. Other Relevant HX: partial L5 paraplegic, large, sacral decubitus, suprapubic catheter. rectosigmoidectomy for fistula turning into non-healing wound, bilateral below knee amputation, OSA, T2DM, Afib, h/o osteomyletis, h/o VTE, pulmonary hypertension,chronic pain, vitamin d deficiency, carpal tunnel, anemia, back
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Heart rate irregular, Lung consolidation, Lung opacity, Memory impairment, Nephrostomy
Clinical narrative: Reported Symptoms: 10011906:DEATH; 10084380:COVID-19 PNEUMONIA; Narrative: Patient was a 77 y.o. male who acquired COVID-19 during a hospital stay where he had a rectosigmoidectomy from this surgery caused a (L) percutaneous nephrostomy tube to be placed. The patient tested positive for COVID-19 infection 08/17/2021 with a PCR test, symptom onset starting on 8/16/2021 . Patient's medical history included sleep apnea, his baseline O2 was 2L with CPAP at night. Upon admission on 8/19/2021 to a facility, he had a non-productive cough. Throughout his hospital stay, he required HFNC and BIPAP. Chest/lung exams showed: decreased/course breath sounds and mild labored breathing. CT/chest x-rays showed: plural effusion and basilar consolidation opacities, and atelectasis. Patient also had presentation of edema in thighs, congestion, high and low BP/HR/RR episodes, irriegular rate and rhythm of heart episodes, and behavioral episodes that consisted of yelling, disorientation, short term memory impairment, hallucinations, delirium. While in the hospital he received dexamethasone, hospital acquired penumonia empiric therapy (vancomycin and Zosyn, later Levaquin as well) and medications for his behavioral episodes. Patient passed away 8/27/2021. Other Relevant HX: partial L5 paraplegic, large, sacral decubitus, suprapubic catheter. rectosigmoidectomy for fistula turning into non-healing wound, bilateral below knee amputation, OSA, T2DM, Afib, h/o osteomyletis, h/o VTE, pulmonary hypertension,chronic pain, vitamin d deficiency, carpal tunnel, anemia, back
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Oedema peripheral, Pleural effusion, Pneumonia, Positive airway pressure therapy, Rectal prolapse repair
Clinical narrative: Reported Symptoms: 10011906:DEATH; 10084380:COVID-19 PNEUMONIA; Narrative: Patient was a 77 y.o. male who acquired COVID-19 during a hospital stay where he had a rectosigmoidectomy from this surgery caused a (L) percutaneous nephrostomy tube to be placed. The patient tested positive for COVID-19 infection 08/17/2021 with a PCR test, symptom onset starting on 8/16/2021 . Patient's medical history included sleep apnea, his baseline O2 was 2L with CPAP at night. Upon admission on 8/19/2021 to a facility, he had a non-productive cough. Throughout his hospital stay, he required HFNC and BIPAP. Chest/lung exams showed: decreased/course breath sounds and mild labored breathing. CT/chest x-rays showed: plural effusion and basilar consolidation opacities, and atelectasis. Patient also had presentation of edema in thighs, congestion, high and low BP/HR/RR episodes, irriegular rate and rhythm of heart episodes, and behavioral episodes that consisted of yelling, disorientation, short term memory impairment, hallucinations, delirium. While in the hospital he received dexamethasone, hospital acquired penumonia empiric therapy (vancomycin and Zosyn, later Levaquin as well) and medications for his behavioral episodes. Patient passed away 8/27/2021. Other Relevant HX: partial L5 paraplegic, large, sacral decubitus, suprapubic catheter. rectosigmoidectomy for fistula turning into non-healing wound, bilateral below knee amputation, OSA, T2DM, Afib, h/o osteomyletis, h/o VTE, pulmonary hypertension,chronic pain, vitamin d deficiency, carpal tunnel, anemia, back
Age: 76.0
Sex: M
Vaccine: COVID19
Symptoms: Respiratory rate decreased, Respiratory rate increased, Respiratory tract congestion, SARS-CoV-2 test positive, Screaming
Clinical narrative: Reported Symptoms: 10011906:DEATH; 10084380:COVID-19 PNEUMONIA; Narrative: Patient was a 77 y.o. male who acquired COVID-19 during a hospital stay where he had a rectosigmoidectomy from this surgery caused a (L) percutaneous nephrostomy tube to be placed. The patient tested positive for COVID-19 infection 08/17/2021 with a PCR test, symptom onset starting on 8/16/2021 . Patient's medical history included sleep apnea, his baseline O2 was 2L with CPAP at night. Upon admission on 8/19/2021 to a facility, he had a non-productive cough. Throughout his hospital stay, he required HFNC and BIPAP. Chest/lung exams showed: decreased/course breath sounds and mild labored breathing. CT/chest x-rays showed: plural effusion and basilar consolidation opacities, and atelectasis. Patient also had presentation of edema in thighs, congestion, high and low BP/HR/RR episodes, irriegular rate and rhythm of heart episodes, and behavioral episodes that consisted of yelling, disorientation, short term memory impairment, hallucinations, delirium. While in the hospital he received dexamethasone, hospital acquired penumonia empiric therapy (vancomycin and Zosyn, later Levaquin as well) and medications for his behavioral episodes. Patient passed away 8/27/2021. Other Relevant HX: partial L5 paraplegic, large, sacral decubitus, suprapubic catheter. rectosigmoidectomy for fistula turning into non-healing wound, bilateral below knee amputation, OSA, T2DM, Afib, h/o osteomyletis, h/o VTE, pulmonary hypertension,chronic pain, vitamin d deficiency, carpal tunnel, anemia, back
Sex: M
Vaccine: FLUX
Symptoms: Guillain-Barre syndrome
Clinical narrative: Reported Symptoms:  10018767:GUILLAIN-BARRE SYNDROME;       Narrative:  GUILLAIN BARRE Other Relevant HX:  Other: GUILLAIN BARRE
Age: 72.0
Sex: M
Vaccine: COVID19
Symptoms: Incorrect dose administered, No adverse event, Product administration error
Clinical narrative: Reported Symptoms:  10067482:NO ADVERSE EVENT;     Narrative: Patient contacted regarding recent COVID-19 immunization on 11/10/21.   Patient erroneously received a full dose of Moderna vaccine instead of a half dose booster per CDC guidelines.   Patient was provided this information and informed  that we would not expect any significant consequences as a result of this error.   Patient was asked about any potential adverse events and none were reported.   the patient was appreciative of the phone call and agreed to contact the  pharmacy or his provider with any additional questions or adverse events.   Other Relevant HX:  Other:  none
Sex: M
Vaccine: COVID19
Symptoms: Anaphylactic reaction, Dysgeusia, Skin warm, Swelling, Swollen tongue
Clinical narrative: Reported Symptoms:  10002218:ANAPHYLAXIS; Narrative:  After 7 minutes after vaccine, patient had tongue swelling and metal taste to his tongue. Had difficulty swelling and hot forehead. Doctor asked staff to call EMS for presumed anaphylaxis. EpiPen was administered. Patient improved with pen injection. He was transferred by ambulance to nearest emergency department for further evaluation. Other Relevant HX:  Other: ANAPHYLAXIS
Sex: F
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Reported Symptoms: 10019211:HEADACHE; Narrative: Other Relevant HX:
Sex: M
Vaccine: COVID19
Symptoms: Tachycardia
Clinical narrative: Reported Symptoms: 10043071:TACHYCARDIA; Narrative: Other Relevant HX: Other: TACHYCARDIA
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Hyperglycaemia
Clinical narrative: Reported Symptoms:  10020639:HYPERGLYCEMIA;     Narrative:   Other Relevant HX:   Other: HYPERGLYCEMIA
Age: 65.0
Sex: M
Vaccine: COVID19
Symptoms: Malaise, Myalgia
Clinical narrative: Reported Symptoms:  10025482:MALAISE;  10028411:MYALGIA;    Narrative:   Other Relevant HX:  Other:  MALAISE
Sex: M
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Reported Symptoms:   10019211:HEADACHE;     Narrative:  Other Relevant HX:  This was the first dose in series, administered 3/30/21.  Patient received 2nd dose in series from another Pharmacy 11/15/21.  Other: Severe headache.
Age: 54.0
Sex: M
Vaccine: FLU4, VARCEL
Symptoms: Hypersensitivity, Myalgia, Neck pain, Paraesthesia, Rash
Clinical narrative: Reported Symptoms: 10028322:MUSCLE PAIN; 10028411:MYALGIA; 10037844:RASH; 10043517:THROAT CONSTRICTION; Narrative: Patient received both influenza and shingrix at the same time. Patient developed severe neck pain with tingling little pains. Patient had small are of rash to the top of the left shoulder and at the back base of skull. Somewhat painful. Determination was allergic reaction to one of the vaccines. Other Relevant HX: Other: RASH; MUSCLE PAIN; AIRWAY CONSTRICTION
Age: 54.0
Sex: M
Vaccine: FLU4, VARCEL
Symptoms: Throat tightness
Clinical narrative: Reported Symptoms: 10028322:MUSCLE PAIN; 10028411:MYALGIA; 10037844:RASH; 10043517:THROAT CONSTRICTION; Narrative: Patient received both influenza and shingrix at the same time. Patient developed severe neck pain with tingling little pains. Patient had small are of rash to the top of the left shoulder and at the back base of skull. Somewhat painful. Determination was allergic reaction to one of the vaccines. Other Relevant HX: Other: RASH; MUSCLE PAIN; AIRWAY CONSTRICTION
Age: 53.0
Sex: F
Vaccine: VARZOS
Symptoms: Pruritus, Rash
Clinical narrative: Reported Symptoms:  10037087:PRURITUS;  10037844:RASH;    Narrative:  2nd zoster vaccine received 7/26/21 caused her to have itching of her head, neck and face.  Pt reports symptoms after the shot  (she could not specify when it started) but no longer having itching and she is fine as of 8/5/21. No symptoms reported after first vaccine (7/16/2020)  Other Relevant HX: Other:  PRURITUS
Age: 93.0
Sex: M
Vaccine: COVID19
Symptoms: COVID-19, Chills, Productive cough, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Reported Symptoms: 10066400:EMERGENCY CARE; 10060907:DISCHARGE; 10084266:COVID-19; 10084355:COVID-19 VIRUS TEST POSITIVE; Narrative: Patient found to be COVID-19 post vaccination on 5/4/21 after presenting to ER with productive cough and fever. Treated conservatively as an outpatient and has recovered. Other Relevant HX: Patient is a 91 year old male with a PMH of HTN, HLD, CAD, AAA, functional deafness, who presented to the ED with 2 day history of cough and sputum production along with fever and chills. Found to be COVID-19 positive on 5/4/21. Appeared to be a mild case of COVID-19 post vaccination. Patient very stable and treated conservatively at home. Called by RN for follow-up of COVID symptoms on 05/05/21 and found t be significantly improved. Other: Positive COVID-10 test on 5/3/21 in the ER, patient treated on an outpatient basis and discharged from ER
Sex: M
Vaccine: FLUX
Symptoms: Nausea, Rash, Tachycardia
Clinical narrative: Reported Symptoms: 10028813:NAUSEA; 10037944:RASH; 10043071:TACHYCARDIA; 10047700;VOMITING;  Narrative: Unclear when influenza reaction occurred, not documented in chart, Adverse allergy was placed after PCP appt where pt reported prior reaction to influenza injection Other Relevant HX: Other: NAUSEA; TACHYCARDIA; RASH
Age: 75.0
Sex: M
Vaccine: FLU4
Symptoms: Burning sensation, Pain, Pruritus, Rash
Clinical narrative: Reported Symptoms:  10037644:RASH;    Narrative:  Patient reported rash three days after vaccine for 10 days with pruritus' when he received flu vaccine. On right side of back.  Burning and itching, no blisters.  No temp.  Painful.  Took abx, prednisone, benadryl and triamcinolone ointment.  Other Relevant HX:  Other:  RASH
Sex: M
Vaccine: COVID19
Symptoms: Brain fog, Disorientation, Dizziness, Euphoric mood, Somnolence
Clinical narrative: Reported Symptoms: 000133395:DISORIENTATION; 10013573:DIZZINESS; 10013649: DROWSYNESS; 10015533:EUPHORIA; 10016876:FOGGY FEELING IN HEAD; 10047508:VISION ABNORMAL;    Narrative:   Other Relevant HX:  Other Relevant HX:  Other: DIZZINESS; DROWSY; DISORIENTED; VISUAL DISTURBANCE; EUPHORIA; feeling foggy
Sex: M
Vaccine: COVID19
Symptoms: Visual impairment
Clinical narrative: Reported Symptoms: 000133395:DISORIENTATION; 10013573:DIZZINESS; 10013649: DROWSYNESS; 10015533:EUPHORIA; 10016876:FOGGY FEELING IN HEAD; 10047508:VISION ABNORMAL;    Narrative:   Other Relevant HX:  Other Relevant HX:  Other: DIZZINESS; DROWSY; DISORIENTED; VISUAL DISTURBANCE; EUPHORIA; feeling foggy
Age: 63.0
Sex: M
Vaccine: COVID19
Symptoms: Death, Haemorrhage
Clinical narrative: Reported Symptoms: 10005183:BLEEDING; 10011906:DEATH;  Narrative: Other Relevant HX:  Other:
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site rash
Clinical narrative: Reported Symptoms: 10037844:RASH; Narrative: Patient who presented 02/16/2021 is a 82 y.o.male patient who developed a rash at the injection site within a couple days after receiving his 1st COVID-19 Pfizer vaccination on 1/26/2021. He was prescribed Hydrocortisone ointment. Other Relevant HX: Hypertension, multinodular goiter, BPH, mixed hyperlipidemia, suspected malignant pigmented sin lesion, diffuse large B-cell lymphoma, inflamed seborrheic keratosis Other:
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: Breakthrough COVID-19, COVID-19, Cough, Malaise, Pyrexia
Clinical narrative: Reported Symptoms: 10067923:VACCINE BREAKTHROUGH INFECTION: Narrative: Patient lives independently in the community. His medical history is significant for obesity, 0SA, COPD and hypertension. The patient had received two doses of Moderna COVID-19 vaccine (01/13/2021 & 02/10/2021). The patient was generally not feeling well for a few days, and tested positive for COVID-19 infection on 09/28/2021. Patient was brought into the emeergency department by his daughter (10/01/2021) for complaints of cough, fever and wheezing despite increased use of albuterol inhaler. Patient was admitted to the medical floor. He denied treatment with remdesivir and/or baricitinib. Patient was treated with oxygen for one day and dexamethasone through his stay. Patient was discharged (10/03/2021) back to his home under the care of his daughter and advised to take dextromethorphan/guaifenesin for cough. Other Relevant HX: Past medical history is significant for: COPD, HTN, and OSA, hearing loss, obese HPI: tested positive from rapid test in community 09/28/2021; 87% oxygen sat on RA Other: COVID-19 Breakthrough Infection
Age: 81.0
Sex: M
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Wheezing
Clinical narrative: Reported Symptoms: 10067923:VACCINE BREAKTHROUGH INFECTION: Narrative: Patient lives independently in the community. His medical history is significant for obesity, 0SA, COPD and hypertension. The patient had received two doses of Moderna COVID-19 vaccine (01/13/2021 & 02/10/2021). The patient was generally not feeling well for a few days, and tested positive for COVID-19 infection on 09/28/2021. Patient was brought into the emeergency department by his daughter (10/01/2021) for complaints of cough, fever and wheezing despite increased use of albuterol inhaler. Patient was admitted to the medical floor. He denied treatment with remdesivir and/or baricitinib. Patient was treated with oxygen for one day and dexamethasone through his stay. Patient was discharged (10/03/2021) back to his home under the care of his daughter and advised to take dextromethorphan/guaifenesin for cough. Other Relevant HX: Past medical history is significant for: COPD, HTN, and OSA, hearing loss, obese HPI: tested positive from rapid test in community 09/28/2021; 87% oxygen sat on RA Other: COVID-19 Breakthrough Infection
Sex: M
Vaccine: FLUX
Symptoms: Guillain-Barre syndrome
Clinical narrative: Reported Symptoms: 10018767:GUILLAIN-BARRE SYNDROME; Narrative: GUILLAIN BARRE Other Relevant HX: Other: GUILLAIN BARRE
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Alcohol withdrawal syndrome, Breakthrough COVID-19, COVID-19, Chills, Cough
Clinical narrative: Reported Symptoms: 10067923:VACCINE BREAKTHROUGH INFECTION; Narrative: Patient is a 55 year old male patient who was recently evicted from his home and moving in with his elderly parents. Patient presented to the emergency department (09/09/2021) for help with alcohol withdrawal symptoms. Patient presented with a dry cough, wheeing and dyspnea on exertion, chills, sore throat and diarrhea. A PCR test confirmed the patient was positive for COVID-19 infection after receiving full coourse of J&J immunization (05/27/2021). He was admitted to the hospital for alcohol detox and required no treatments for the COVID-19 infection. Patient was discharged on 9/15/2021 into the care of his parents. Other Relevant HX: Alcohol abuse, withdrawl seizures, substance abuse (methamphetamine and smokes meth), spinal stenosis, GERD, BPH, loss of vision in R eye, h/o hematuria, paroxysnal Afib, recurrent major depressive disorder, tobacco use, h/o: vasactomy, lasik surgery, arthroscopic surgery repair Other: COVID-19 breakthrough infection
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Dyspnoea exertional, Oropharyngeal pain, SARS-CoV-2 test positive, Wheezing
Clinical narrative: Reported Symptoms: 10067923:VACCINE BREAKTHROUGH INFECTION; Narrative: Patient is a 55 year old male patient who was recently evicted from his home and moving in with his elderly parents. Patient presented to the emergency department (09/09/2021) for help with alcohol withdrawal symptoms. Patient presented with a dry cough, wheeing and dyspnea on exertion, chills, sore throat and diarrhea. A PCR test confirmed the patient was positive for COVID-19 infection after receiving full coourse of J&J immunization (05/27/2021). He was admitted to the hospital for alcohol detox and required no treatments for the COVID-19 infection. Patient was discharged on 9/15/2021 into the care of his parents. Other Relevant HX: Alcohol abuse, withdrawl seizures, substance abuse (methamphetamine and smokes meth), spinal stenosis, GERD, BPH, loss of vision in R eye, h/o hematuria, paroxysnal Afib, recurrent major depressive disorder, tobacco use, h/o: vasactomy, lasik surgery, arthroscopic surgery repair Other: COVID-19 breakthrough infection
Sex: M
Vaccine: FLUX
Symptoms: Unevaluable event
Clinical narrative: Reported Symptoms: 10054112:HOSPITALISATION; Narrative: Unknown reaction resulting in 1 month hospitalization in the 1970s Other Relevant HX: Other: HOSPITALIZATION
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chills, Cough, Diarrhoea, Dyspnoea exertional
Clinical narrative: Reported Symptoms: 10084268:COVID-19; Narrative: Patient is a 47 y.o. female patient who tested positive for COVID-19 on 8/22/2021. She was admitted on 08/24/2021. On 8/22/2021 she presented to the ED with a sore throat, productive/persistent/severe cough, mild shortness of breath, diarrhea, and nausea. 08/24/2021 she was admitted with a continued cough, nausea, diarrhea, shortness of breath on exertion, and new symptoms of congestion, fatigue, body aches, chills, fever. Her O2 saturation had several dips to 88%. She was treated with remdesivir (1 day) and dexamethasone (2 days). Patient was discharged 08/25/2021 with no new medications. Other revelant HX: Morbid obesity, impulse control disorder, migraine, fibrocystic disease of breast Other: COVID-19
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Nausea, Oropharyngeal pain, Oxygen saturation decreased, Pain
Clinical narrative: Reported Symptoms: 10084268:COVID-19; Narrative: Patient is a 47 y.o. female patient who tested positive for COVID-19 on 8/22/2021. She was admitted on 08/24/2021. On 8/22/2021 she presented to the ED with a sore throat, productive/persistent/severe cough, mild shortness of breath, diarrhea, and nausea. 08/24/2021 she was admitted with a continued cough, nausea, diarrhea, shortness of breath on exertion, and new symptoms of congestion, fatigue, body aches, chills, fever. Her O2 saturation had several dips to 88%. She was treated with remdesivir (1 day) and dexamethasone (2 days). Patient was discharged 08/25/2021 with no new medications. Other revelant HX: Morbid obesity, impulse control disorder, migraine, fibrocystic disease of breast Other: COVID-19
Age: 47.0
Sex: F
Vaccine: COVID19
Symptoms: Productive cough, Pyrexia, Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: Reported Symptoms: 10084268:COVID-19; Narrative: Patient is a 47 y.o. female patient who tested positive for COVID-19 on 8/22/2021. She was admitted on 08/24/2021. On 8/22/2021 she presented to the ED with a sore throat, productive/persistent/severe cough, mild shortness of breath, diarrhea, and nausea. 08/24/2021 she was admitted with a continued cough, nausea, diarrhea, shortness of breath on exertion, and new symptoms of congestion, fatigue, body aches, chills, fever. Her O2 saturation had several dips to 88%. She was treated with remdesivir (1 day) and dexamethasone (2 days). Patient was discharged 08/25/2021 with no new medications. Other revelant HX: Morbid obesity, impulse control disorder, migraine, fibrocystic disease of breast Other: COVID-19
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Agitation, Breath sounds abnormal, COVID-19, COVID-19 pneumonia, Confusional state
Clinical narrative: Reported Symptoms: 10084380:COVID-19 PNEUMONIA;  Narrative: Patient is a 87 y.o. male patient who tested positive for COIVD-19 after getting both doses of the pfizer vaccine. Presenting to the hospital, he had a fever, urinary incontinence, and encephalopathy. He has a history of COPD, which his baseline oxygen use is 3L. While hospitalized, he was requiring as high as 5-6 L of oxgen, experienced hallucinations, agitation, confusion, and had diminished breaths sounds along with lung opacities. The patient was treated with ceftriaxone for a confirmed UTI, as well as remdesivir and dexamethasone. Admission dates were 8/21/21 - 9/7/21, and discharged back to his previous residence (assisted living facility). Other Relevant HX: Oxygen dependency, COPD, CAD, HTN, Hyperlipidema, GERD, blind, aneurysm of abdominal aorta repair, blindness, constipation, unintentional weight loss Other: COVID-19 pneumonia
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Encephalopathy, Hallucination, Lung opacity, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: Reported Symptoms: 10084380:COVID-19 PNEUMONIA;  Narrative: Patient is a 87 y.o. male patient who tested positive for COIVD-19 after getting both doses of the pfizer vaccine. Presenting to the hospital, he had a fever, urinary incontinence, and encephalopathy. He has a history of COPD, which his baseline oxygen use is 3L. While hospitalized, he was requiring as high as 5-6 L of oxgen, experienced hallucinations, agitation, confusion, and had diminished breaths sounds along with lung opacities. The patient was treated with ceftriaxone for a confirmed UTI, as well as remdesivir and dexamethasone. Admission dates were 8/21/21 - 9/7/21, and discharged back to his previous residence (assisted living facility). Other Relevant HX: Oxygen dependency, COPD, CAD, HTN, Hyperlipidema, GERD, blind, aneurysm of abdominal aorta repair, blindness, constipation, unintentional weight loss Other: COVID-19 pneumonia
Age: 86.0
Sex: M
Vaccine: COVID19
Symptoms: Urinary incontinence, Urinary tract infection
Clinical narrative: Reported Symptoms: 10084380:COVID-19 PNEUMONIA;  Narrative: Patient is a 87 y.o. male patient who tested positive for COIVD-19 after getting both doses of the pfizer vaccine. Presenting to the hospital, he had a fever, urinary incontinence, and encephalopathy. He has a history of COPD, which his baseline oxygen use is 3L. While hospitalized, he was requiring as high as 5-6 L of oxgen, experienced hallucinations, agitation, confusion, and had diminished breaths sounds along with lung opacities. The patient was treated with ceftriaxone for a confirmed UTI, as well as remdesivir and dexamethasone. Admission dates were 8/21/21 - 9/7/21, and discharged back to his previous residence (assisted living facility). Other Relevant HX: Oxygen dependency, COPD, CAD, HTN, Hyperlipidema, GERD, blind, aneurysm of abdominal aorta repair, blindness, constipation, unintentional weight loss Other: COVID-19 pneumonia
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, COVID-19, COVID-19 pneumonia, Chest X-ray abnormal, Chills
Clinical narrative: Reported Symptoms: 10084380:COVID-19 PNEUMONIA; Narrative: Received full vaccination course in May 2021. Presented to the ED on 8/21/21 with c/o wheezing, cough and SOB for 4-5 days. Tested positive for COVID-19. Admitted to the hospital on 8/21/21 and initiated treatment with remdesivir, dexamethasone and albuterol. Started on oxygen. Felt improvied and discharged on 8/23/21. Returned to ED on 8/24/21 with c/o of increasing weakness, chills, tachycardia. Chest x-ray consistent with COVID pneumonia. Was admitted overnight for observation, resumed dexamethasone and returned home on 8/25/21. Returned to ED on 8/29/21 with worsened cough, but physician felt paitent was stable so returned home and completed recovery. Other Relevant HX: Comorbidities included bipolar disorder, fibromyalgia, PTSD, chronic pain, migraines, morbid obesity, diabetes, hypothyroidism, OSA, mild cognitive impairment Other: COVID 19 pneumonia
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Cough, Dyspnoea, SARS-CoV-2 test positive, Tachycardia, Wheezing
Clinical narrative: Reported Symptoms: 10084380:COVID-19 PNEUMONIA; Narrative: Received full vaccination course in May 2021. Presented to the ED on 8/21/21 with c/o wheezing, cough and SOB for 4-5 days. Tested positive for COVID-19. Admitted to the hospital on 8/21/21 and initiated treatment with remdesivir, dexamethasone and albuterol. Started on oxygen. Felt improvied and discharged on 8/23/21. Returned to ED on 8/24/21 with c/o of increasing weakness, chills, tachycardia. Chest x-ray consistent with COVID pneumonia. Was admitted overnight for observation, resumed dexamethasone and returned home on 8/25/21. Returned to ED on 8/29/21 with worsened cough, but physician felt paitent was stable so returned home and completed recovery. Other Relevant HX: Comorbidities included bipolar disorder, fibromyalgia, PTSD, chronic pain, migraines, morbid obesity, diabetes, hypothyroidism, OSA, mild cognitive impairment Other: COVID 19 pneumonia
Age: 78.0
Sex: M
Vaccine: PPV, PPV
Symptoms: Rash
Clinical narrative: Reported Symptoms: 10037844:RASH; Narrative: Developed a rash 24 hours later. Went to the ER for check up. Was taking allerga. Had previous rash to first dose 6 years ago. Other Relevant HX: RASH